Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc.ANEB · Entity 9617 | Director · Chief Executive Officer | December 09, 2022 | December 14, 2022 |
| CohBar, Inc.CWBR · Entity 124935 | Chief Executive Officer | March 29, 2018 | April 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anebulo Pharmaceuticals, Inc.
Report date December 09, 2022 · Filed December 14, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.37 · Expires 2032-12-08 | Direct | 70,246 |
Reported balance
After 2022-12-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-12-09 · Grant · Acquired 70,246 · Balance 70,246 F1: The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022.
CohBar, Inc.
Report date March 29, 2018 · Filed April 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.30 · Expires 2021-03-29 | Direct | 2,000 |
Reported balance
After 2018-03-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-03-29 · Purchase · Acquired 2,000 · Balance 2,000 F1: The subject warrant was issued pursuant to a Note and Warrant Purchase Agreement (the "Agreement") between the Issuer and the Reporting Person. Purchasers under the Agreement received a warrant to purchase one share of common stock for each $5.00 original principal amount of the non-convertible unsecured promissory note purchased under the Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: The subject warrant was issued pursuant to a Note and Warrant Purchase Agreement (the "Agreement") between the Issuer and the Reporting Person. Purchasers under the Agreement received a warrant to purchase one share of common stock for each $5.00 original principal amount of the non-convertible unsecured promissory note purchased under the Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2022 Filed Dec 14, 2022 02:18 UTC | Anebulo Pharmaceuticals, Inc. ANEB · Entity 9617 | GrantStock Option (right to buy) · Derivative | 70,246 | $0.00 Strike: $3.37 | $0.00 |
DisclosureSEC source: 0001209191-22-061091 · doc4.xml · derivative · entry 1 ALLEN SIMON · CIK 0001606829 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,246 Underlying: Common Stock · 70,246 shares Expires 2032-12-08 F1 · derivative.exercise_date: The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022. Read SEC document |
| June 27, 2022 Filed Oct 3, 2022 23:48 UTC | Anebulo Pharmaceuticals, Inc. ANEB · Entity 9617 | GrantStock Option (right to buy) · Derivative | 77,457 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001209191-22-051980 · doc4.xml · derivative · entry 1 ALLEN SIMON · CIK 0001606829 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,457 Underlying: Common Stock · 77,457 shares Expires 2027-07-31 F1 · derivative.exercise_date: 4,841 shares vest immediately. The remainder of the shares vest ratably in 15 quarterly installments (4,841.06 shares each Quarter) from July 1, 2022 through January 1, 2026. All shares subject to the option will vest immediately upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of the option on June 23, 2022. Read SEC document |
| February 07, 2022 Filed Feb 7, 2022 21:07 UTC | Anebulo Pharmaceuticals, Inc. ANEB · Entity 9617 | GrantOption to purchase Common Stock · Derivative | 625,000 | $0.00 Strike: $6.15 | $0.00 |
DisclosureSEC source: 0001493152-22-003365 · ownership.xml · derivative · entry 1 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2027-01-31 F1 · security: Mr. Allen received a stock option to purchase 625,000 shares of the Issuer's common stock pursuant to the Issuer's 2020 Stock Incentive Plan, which will vest in equal quarterly installments commencing on April 1, 2022 through January 1, 2026. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 13:50 UTC | CohBar, Inc. CWBR · Entity 124935 | PurchaseWarrants (right to buy) · Derivative | 2,000 | Not disclosed Strike: $5.30 | Not disclosed |
DisclosureSEC source: 0001209191-18-022302 · doc4.xml · derivative · entry 1 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2021-03-29 F1 · price: The subject warrant was issued pursuant to a Note and Warrant Purchase Agreement (the "Agreement") between the Issuer and the Reporting Person. Purchasers under the Agreement received a warrant to purchase one share of common stock for each $5.00 original principal amount of the non-convertible unsecured promissory note purchased under the Agreement. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 18:16 UTC | CohBar, Inc. CWBR:OTCQX · Entity 124935 | GrantWarrant (right to buy) · Derivative | 10,000 | Not disclosed Strike: $2.25 | Not disclosed |
DisclosureSEC source: 0001209191-17-045572 · doc4.xml · derivative · entry 2 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2020-06-30 F1 · price: The reported securities are included within units purchased by the reporting person from the issuer for $1.50 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 18:16 UTC | CohBar, Inc. CWBR:OTCQX · Entity 124935 | GrantCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-045572 · doc4.xml · nonDerivative · entry 1 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,200 F1 · price: The reported securities are included within units purchased by the reporting person from the issuer for $1.50 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:20 UTC | CohBar, Inc. CWBR:OTCQX · Entity 124935 | SaleCommon Stock | 35 | $1.89 | $66.15 |
DisclosureSEC source: 0001209191-17-007348 · doc4.xml · nonDerivative · entry 4 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by spouse Disclosed balance after: 0 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:20 UTC | CohBar, Inc. CWBR:OTCQX · Entity 124935 | SaleCommon Stock | 100 | $2.10 | $210.00 |
DisclosureSEC source: 0001209191-17-007348 · doc4.xml · nonDerivative · entry 3 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by spouse Disclosed balance after: 35 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:20 UTC | CohBar, Inc. CWBR:OTCQX · Entity 124935 | PurchaseCommon Stock | 200 | $2.30 | $460.00 |
DisclosureSEC source: 0001209191-17-007348 · doc4.xml · nonDerivative · entry 2 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 21:20 UTC | CohBar, Inc. CWBR:OTCQX · Entity 124935 | PurchaseCommon Stock | 135 | $2.48 | $334.80 |
DisclosureSEC source: 0001209191-17-007348 · doc4.xml · nonDerivative · entry 1 ALLEN SIMON · CIK 0001606829 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by spouse Disclosed balance after: 135 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.